Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1980;2:243-255

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kuhn, D. M.
Right arrow Articles by Lovenberg, W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kuhn, D. M.
Right arrow Articles by Lovenberg, W.

Hypertension, Vol 2, 243-255, Copyright © 1980 by American Heart Association


ARTICLES

Review of the role of the central serotonergic neuronal system in blood pressure regulation

DM Kuhn, WA Wolf and W Lovenberg

Alterations in the dynamics of brain serotonin biosynthesis can lead to changes in cardiovascular function. It appears that the activation of cerebral serotonin receptors produces a pressor effect in normotensive rats but produces a depressor effect in normotensive cats or dogs. On the other hand, reductions in the levels of serotonin can prevent the onset of hypertension in some experimental hypertensive models and lower the blood pressure of organisms with established hypertension. The ability of brain serotonin to modulate arterial blood pressure may be mediated by the influences of the serotonergic neuronal systems on efferent sympathetic activity. Finally, the reduction in sympathetic outflow produced by increasing brain serotonin levels in dogs protects the heart against ventricular fibrillation and may, therefore, constitute a reasonable adjunct in the management of high-risk, cardiac- arrest patients.


This article has been cited by other articles:


Home page
EuropaceHome page
J. C. Guzman, R. G. Garcia, R. Dillenburg, F. S. Sieger, P. Lopez-Jaramillo, and C. A. Morillo
Central serotoninergic response to orthostatic challenge in patients with neurocardiogenic syncope.
Europace, April 1, 2006; 8(4): 306 - 311.
[Abstract] [Full Text] [PDF]


Home page
NEJMHome page
B. P. Grubb
Neurocardiogenic Syncope
N. Engl. J. Med., March 10, 2005; 352(10): 1004 - 1010.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. A. Moffitt and A. K. Johnson
Short-term fluoxetine treatment enhances baroreflex control of sympathetic nervous system activity after hindlimb unloading
Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2004; 286(3): R584 - R590.
[Abstract] [Full Text] [PDF]


Home page
J Child NeurolHome page
M.R. Pranzatelli, S.G. Pavlakis, R.J. Gould, and D.C. De Vivo
Hypothalamic-Midbrain Dysregulation Syndrome: Hypertension, Hyperthermia, Hyperventilation, and Decerebration
J Child Neurol, April 1, 1991; 6(2): 115 - 122.
[Abstract] [PDF]